BSX vs. COO: Boston Scientific vs. Cooper Stock Comparison
How do Boston Scientific (BSX) and Cooper (COO) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Boston Scientific (BSX) and Cooper (COO) both belong to the Health Care Equipment & Supplies industry, though BSX is classified under Health Care Equipment while COO falls under Health Care Supplies.
| Profile Item | BSX | COO |
|---|---|---|
| Name | Boston Scientific Corp. | The Cooper Companies, Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Supplies |
| Market Capitalization | 61.96 billion USD | 11.86 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | Nasdaq |
| Listing Date | May 19, 1992 | January 21, 1983 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BSX | COO |
|---|---|---|
| Total Return (1Y) | -55.98% | -9.72% |
| Total Return (3Y, Annualized) | -5.05% | -8.06% |
| Total Return (5Y, Annualized) | 0.57% | -10.20% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BSX | COO |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 32.67% |
| Beta (5Y) | 0.57 | 0.79 |
| Max Drawdown (5Y) | -61.55% | -52.11% |
| Avg. Volume (3M) | 19.73M | 3.47M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BSX | COO |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | -0.43 |
| Sortino Ratio (1Y) | -1.80 | -0.59 |
Profitability
ROE (TTM)
Both Boston Scientific (BSX) at 14.12% and Cooper (COO) at 6.84% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
COO
Health Care Equipment & Services industry group
6.84%
- Max
- 47.61%
- Q3
- 14.36%
- COO
- 6.84%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Boston Scientific (BSX) at 16.62% and Cooper (COO) at 13.46% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
COO
Health Care Equipment & Services industry group
13.46%
- Max
- 29.35%
- COO
- 13.46%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Boston Scientific (BSX) at 19.05% and Cooper (COO) at 20.82% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
COO
Health Care Equipment & Services industry group
20.82%
- Max
- 35.43%
- COO
- 20.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BSX | COO |
|---|---|---|
| ROE (TTM) | 14.12% | 6.84% |
| ROA (TTM) | 5.87% | 2.74% |
| Net Margin (TTM) | 16.62% | 13.46% |
| Operating Margin (TTM) | 19.05% | 20.82% |
| Gross Margin (TTM) | 67.98% | 65.93% |
Growth
Revenue Growth
Both Boston Scientific (BSX) at 19.87% and Cooper (COO) at 5.06% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Boston Scientific (BSX) at 55.20% sits in the top EPS growth quartile, while Cooper (COO) at -4.59% is closer to the peer norm — faster per-share earnings growth for BSX.
Growth Metrics
| Metric | BSX | COO |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | 5.06% |
| Revenue Growth (3Y CAGR) | 16.54% | 7.35% |
| EPS Growth (YoY) | 55.20% | -4.59% |
| EPS Growth (3Y CAGR) | 62.75% | -1.22% |
Financial Strength
Current Ratio (MRQ)
Both Boston Scientific (BSX) at 1.37 and Cooper (COO) at 1.22 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
COO
Health Care Equipment & Services industry group
1.22
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- COO
- 1.22
- Min
- 0.30
Debt / Equity (MRQ)
Both Boston Scientific (BSX) at 0.46 and Cooper (COO) at 0.34 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
COO
Health Care Equipment & Services industry group
0.34
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- COO
- 0.34
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BSX | COO |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 1.22 |
| Debt / Equity (MRQ) | 0.46 | 0.34 |
| Net Debt / EBITDA | 2.04 | 2.84 |
Dividends
Dividend Yield (TTM)
Neither Boston Scientific (BSX) nor Cooper (COO) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
COO
Health Care Equipment & Services industry group
0.00%
- COO
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Boston Scientific (BSX) nor Cooper (COO) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
COO
Health Care Equipment & Services industry group
0.00%
- COO
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BSX | COO |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Boston Scientific (BSX) at 18.04 sits in the cheaper P/E ratio quartile, while Cooper (COO) at 21.43 is closer to its industry’s usual earnings multiple — a discount for BSX, though growth and earnings durability still matter.
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
COO
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- COO
- 21.43
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Boston Scientific (BSX) at 2.94 and Cooper (COO) at 2.80 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
COO
Health Care Equipment & Services industry group
2.80
- Max
- 8.80
- Q3
- 4.32
- COO
- 2.80
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Cooper (COO) at 1.42 sits in the lower P/B ratio quartile against book while Boston Scientific (BSX) at 2.42 is valued near its industry’s middle — COO is cheaper on assets, though weigh it against ROE and asset quality.
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
COO
Health Care Equipment & Services industry group
1.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- COO
- 1.42
- Min
- -1.31
Valuation Metrics
| Metric | BSX | COO |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | 21.43 |
| P/S Ratio (TTM) | 2.94 | 2.80 |
| P/B Ratio (MRQ) | 2.42 | 1.42 |
| Free Cash Flow Yield (TTM) | 4.02% | 4.58% |